Beta-endorphin binds to kidney membranes through two distinct sites — a high-affinity opioid receptor and a high-capacity non-opioid site — suggesting most kidney effects may bypass traditional opioid receptors.
Non-opioid binding dominatesThe high-capacity non-opioid binding site on kidney membranes may mediate most of beta-endorphin's renal effects
What the researchers found
Beta-endorphin binds to kidney membranes through both opioid (high-affinity, low-capacity) and non-opioid (low-affinity, high-capacity) sites. The non-opioid binding involves the mid-portion of the peptide.
Why it matters
Beta-endorphin affects kidney function, and most of this may work through non-opioid mechanisms. This is important for understanding how opioid drugs affect kidney function.
How the study worked
Radioiodinated beta-endorphin binding to rat renal basolateral membranes was characterized by saturation isotherms, competition with naloxone and other opioid peptides, and Scatchard analysis.
What this study cannot tell us
In-vitro binding study. The functional consequences of non-opioid binding in the kidney were not tested. Only one species was examined.
How to read the evidence
Preliminary in-vitro binding study in rat kidneys. Characterizes binding sites but does not test functional consequences.
When this study was published
Published in 1990. Non-opioid effects of beta-endorphin remain an active research area.
The bigger picture
The kidney is critical for fluid balance and blood pressure. Finding that beta-endorphin affects kidneys mainly through non-opioid mechanisms means that opioid-blocking drugs may not prevent all of opioid peptides' kidney effects — important for understanding opioid drug side effects on kidney function.
Questions still open
- What kidney functions are regulated by the non-opioid beta-endorphin binding site?
- Are these non-opioid kidney effects clinically significant for patients on opioid therapy?
Common questions
What does non-opioid binding mean?
Why does this matter for kidney function?
Read the original research
Specific binding of beta-endorphin to the isolated renal basolateral membranes in vitro.
Chemical & pharmaceutical bulletin, 38(12), 3395-9
Citation
Sato, H; Takeda, K; Terasaki, T; Tsuji, A. (1990). Specific binding of beta-endorphin to the isolated renal basolateral membranes in vitro.. Chemical & pharmaceutical bulletin, 38(12), 3395-9.